Editorial Commentary
Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
Translational Cancer Research
2019;
8
(7)
:2508-2509
.
(28 November 2019)
Importance of measurement repeatability of semi-quantitative imaging through PET-CT and PET-MR imaging in oncology
Translational Cancer Research
2019;
8
(7)
:2510-2513
.
(28 November 2019)
First-line pembrolizumab in programmed death ligand 1 positive non-small cell lung cancer
Translational Cancer Research
2019;
8
(7)
:2514-2516
.
(28 November 2019)
Original Article
LncRNA-DANCR promotes growth and metastasis of colorectal cancer via activating epithelial-mesenchymal transition process
Translational Cancer Research
2019;
8
(7)
:2517-2525
.
(28 November 2019)
LncRNA MVIH knockdown inhibits the malignancy progression through downregulating miR-505 mediated HMGB1 and CCNE2 in acute myeloid leukemia
Translational Cancer Research
2019;
8
(7)
:2526-2534
.
(28 November 2019)
Jumonji domain containing 5 is a potential prognostic indicator in non-small cell lung cancer patients who received platinum-based chemotherapy
Translational Cancer Research
2019;
8
(7)
:2535-2542
.
(28 November 2019)
Up-regulated GGA3 promotes non-small cell lung cancer proliferation by regulating TrkA receptor
Translational Cancer Research
2019;
8
(7)
:2543-2551
.
(28 November 2019)
Systemic inflammatory response predicts poor prognoses in Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma with transarterial chemoembolization: a prospective study
Translational Cancer Research
2019;
8
(7)
:2552-2563
.
(28 November 2019)
A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation
Translational Cancer Research
2019;
8
(7)
:2564-2569
.
(28 November 2019)
GPX7 promotes the growth of human papillary thyroid carcinoma via enhancement of cell proliferation and inhibition of cell apoptosis
Translational Cancer Research
2019;
8
(7)
:2570-2580
.
(28 November 2019)
Analysis of real-word mutations of lung cancer driver genes in five regions of China
Translational Cancer Research
2019;
8
(7)
:2581-2592
.
(28 November 2019)
STAT3 activation regulated circ-STAT3.46 promote expression of IGF1R by sponging of miR-139-5p in human colon cancer
Translational Cancer Research
2019;
8
(7)
:2593-2601
.
(28 November 2019)
Huisheng Oral Solution exerts anti-tumor effects by downregulating tissue factor and inhibiting the expression of metastasis-related factors, CD44, MMP2, and VEGF
Translational Cancer Research
2019;
8
(7)
:2602-2612
.
(28 November 2019)
A new enhanced recovery after surgery pathway for left-sided pancreatic cancer patients after distal pancreatectomy
Translational Cancer Research
2019;
8
(7)
:2613-2620
.
(28 November 2019)
Brief Report
A novel cancer stem cell-based classification model for the tumorigenesis and development of colorectal cancer
Translational Cancer Research
2019;
8
(7)
:2621-2623
.
(28 November 2019)
Review Article
Progress in the diagnosis and treatment of paraganglioma
Translational Cancer Research
2019;
8
(7)
:2624-2635
.
(28 November 2019)
Long non-coding RNAs in non-small cell lung cancer: functions and distinctions from other malignancies
Translational Cancer Research
2019;
8
(7)
:2636-2653
.
(28 November 2019)
The malignancy among gastric submucosal tumor
Translational Cancer Research
2019;
8
(7)
:2654-2666
.
(28 November 2019)
Case Report
Appendiceal mucinous cystadenoma presenting as abdominal internal hernia: a case report
Translational Cancer Research
2019;
8
(7)
:2667-2671
.
(28 November 2019)
A recurrent giant retroperitoneal myxoid liposarcoma: a case report and literature review
Translational Cancer Research
2019;
8
(7)
:2672-2676
.
(28 November 2019)
Letter to the Editor
ONECUT2 as a new therapeutic target in androgen receptor-indifferent prostate cancer
Translational Cancer Research
2019;
8
(7)
:2677-2679
.
(28 November 2019)
